As a positive control for detection of the canonical p53 targets, non-induced BC-3 cells were treated with Nutlin-3 (here referred to as Nutlin), a small molecule that binds and inhibits MDM2, stabilizing p53 and inducing a potent p53 response. This evidence concerns the gene TP53 and breast cancer.